Jeffrey H. Samet MD, MA, MPH

Published on 10/11/2025

El-Bassel N, Samet JH, Cheng DM, Freisthler B, John Winhusen T, Walsh SL. Response to the Editor: Re: registration and multiple outcome testing in the HEALing Communities Study by Dennis M. Gorman and Ben G. Fitzpatrick. Int J Drug Policy. 2025 Nov; 145:105029. PMID: 41077014.

Published on 9/26/2025

Katz R, Fisher T, Singer-Clark T, Soares Iii W, Carpenter J, Schuessler N, Stadler H, Sahovey A, McAlearney AS, Samet JH, Chatterjee A. Creation of a telehealth addiction consultation service at a rural hospital: a case study. Addict Sci Clin Pract. 2025 Sep 26; 20(1):76. PMID: 41013782.

Published on 8/1/2025

Tsui JI, Bhatraju EP, Hallgren KA, Rhew IC, Samet JH. High-Dose Buprenorphine Treatment in the Setting of Fentanyl. JAMA Netw Open. 2025 Aug 01; 8(8):e2528119. PMID: 40839262.

Published on 7/29/2025

Guyatt P, Babe G, Gayowsky A, Rosic T, Rodrigues M, Bach P, Perez R, de Oliveira C, Samet JH, Kerkerian G, Hann J, Dionne JC, Ahmed A, Kim D, Nolan S, Thabane L, Samaan Z, Dennis BB. Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study. Drug Alcohol Depend Rep. 2025 Sep; 16:100368. PMID: 40837618.

Published on 7/9/2025

Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785. PMID: 40684522.

Published on 7/3/2025

Tilhou AS, Assoumou SA, Samet JH. Aligning Efforts to Boost Medications for Opioid Use Disorder and Pre-Exposure Prophylaxis for HIV. J Gen Intern Med. 2025 Jul 03. PMID: 40610667.

Published on 6/1/2025

Magane KM, Dukes KA, Fielman S, Palfai TP, Regan D, Cheng DM, Lee H, Kraemer KL, Bullard MJ, Chen CA, Samet JH. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):635-645. PMID: 40257810.

Published on 5/26/2025

Levin FR, Oyler DR, Babineau DC, Villani J, Chandler RK, Freeman PR, Alford DP, Fareed N, Mack N, Nguyen TQ, Walker DM, Adams J, Baker TJ, Beers D, Benjamin SN, Bhuiyan J, Blevins D, David JL, Dalvi N, D'Costa L, Feaster DJ, Glasgow L, Goddard-Eckrich DA, Han Y, Harris M, Hunt T, Knott C, Matson A, Mierzwa F, Newman L, Nunes EV, Oga EA, Roberts MF, Shadwick A, Shoben A, Slavova S, Stinson L, Zarkin GA, Freisthler B, Samet JH, Walsh SL, Winhusen TJ, Jackson RD, El-Bassel N. Do Communities Implementing the Communities That HEAL Intervention Have Significantly Lower Rates of High-Risk Opioid Prescribing and Dispensing? AJPM Focus. 2025 Dec; 4(6):100371. PMID: 41035949.

Published on 4/25/2025

Chavez LJ, Yu O, Wartko PD, Braciszewski JM, Glass JE, Horigian VE, Arnsten JH, Murphy MT, Stotts AL, Bagley SM, Lapham GT, Samet JH. Opioid use disorder medications among youth in primary care: Subgroup analysis of the PROUD trial. Pediatr Open Sci. 2025; 1(2). PMID: 40718732.

Published on 4/11/2025

Gilbert L, Chahine R, Chandler R, Feaster DJ, Kim E, Aldridge A, Bagley S, Balvanz P, Fernandez S, Rock P, Vickers-Smith RA, Villani J, Battaglia T, Brown J, Bush H, Chase RP, Collins T, D'Costa L, Damato-MacPherson C, David JL, Defiore-Hyrmer J, Freeman PR, Glasgow L, Hammerslag LR, Hotchkiss J, Hunt T, Hussain S, Kamanu V, Knott C, Knudsen HK, LaRochelle M, Laudate A, Lyons M, McMullan J, Nakayima J, Schackman BR, Slavova S, Tan S, Vandergrift N, Walters ST, Westgate PM, Wu E, Young AM, Zarkin GA, Freisthler B, Oga E, Samet JH, Walsh SL, Winhusen J, Jackson R, El-Bassel N. The effectiveness of the communities that HEAL intervention on reducing non-fatal opioid overdoses: A prespecified secondary analysis of a waitlist cluster control randomized controlled trial. Int J Drug Policy. 2025 Jun; 140:104798. PMID: 40220509.